High dose of interferonα (IFN) plus ribavirin (RIBA) for 6 or 12 months in non responder (NR) patients with chronic hepatitis C (CHC): Results of a randomized trial
P. Andreone, C. Cursaro, A. Gramenzi, M. Margotti, E. Ferri, S. Talarico, L. Di Giammarino, R. Carella, A. D'Errico, M. Spinosa, P. Spagnuolo, M. BernardiVolume:
32
Year:
2000
Language:
english
DOI:
10.1016/s0168-8278(00)80775-8
File:
PDF, 115 KB
english, 2000